Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Thyroxine measurement
|
phenotype |
|
Laboratory Procedure
|
24
|
42
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Sex hormone binding globulin measurement
|
phenotype |
|
Laboratory Procedure
|
11
|
21
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Icterus
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
241
|
17
|
0.100 |
None |
|
0 |
|
|
|
Abdominal Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
302
|
18
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the skeletal system
|
disease |
|
Anatomical Abnormality
|
148
|
18
|
0.100 |
None |
|
0 |
|
|
|
Abnormal pigmentation
|
phenotype |
|
Finding
|
58
|
5
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of the gastric mucosa
|
disease |
|
Anatomical Abnormality
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
Hyperbilirubinemia, Neonatal
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
33
|
15
|
0.060 |
None |
1.000 |
6 |
3
|
2009 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
1.000 |
5 |
2
|
2008 |
2017 |
Hyperlipidemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
472
|
83
|
0.050 |
None |
1.000 |
5 |
2
|
2010 |
2019 |
Leukopenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
440
|
153
|
0.040 |
None |
1.000 |
4 |
1
|
2009 |
2016 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.040 |
None |
1.000 |
4 |
|
2002 |
2019 |
Hypercholesterolemia, Familial
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
203
|
1423
|
0.040 |
None |
0.750 |
4 |
1
|
2006 |
2016 |
Hypercholesterolemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
489
|
123
|
0.040 |
None |
1.000 |
4 |
1
|
2012 |
2019 |
Tuberculosis
|
disease |
Infections
|
Disease or Syndrome
|
1256
|
328
|
0.040 |
None |
1.000 |
4 |
3
|
2015 |
2020 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.040 |
None |
1.000 |
4 |
1
|
2013 |
2019 |
Neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
389
|
97
|
0.040 |
None |
1.000 |
4 |
1
|
2009 |
2016 |
Childhood Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1096
|
261
|
0.030 |
None |
1.000 |
3 |
1
|
2011 |
2019 |
Myalgia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Sign or Symptom
|
226
|
22
|
0.030 |
None |
1.000 |
3 |
3
|
2012 |
2015 |
Hyperlipoproteinemia Type IIa
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
201
|
661
|
0.030 |
None |
0.667 |
3 |
1
|
2012 |
2016 |
Fatty Liver Disease
|
disease |
|
Disease or Syndrome
|
741
|
81
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2017 |
Renal Insufficiency
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
615
|
42
|
0.030 |
None |
1.000 |
3 |
1
|
2019 |
2019 |